A detailed history of State Of Wisconsin Investment Board transactions in Merus N.V. stock. As of the latest transaction made, State Of Wisconsin Investment Board holds 166,518 shares of MRUS stock, worth $8.27 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
166,518
Previous 153,038 8.81%
Holding current value
$8.27 Million
Previous $9.06 Million 8.13%
% of portfolio
0.02%
Previous 0.03%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$47.19 - $58.84 $636,121 - $793,163
13,480 Added 8.81%
166,518 $8.32 Million
Q2 2024

Aug 14, 2024

BUY
$39.81 - $60.2 $5.19 Million - $7.84 Million
130,307 Added 573.26%
153,038 $9.06 Million
Q1 2024

May 14, 2024

SELL
$28.03 - $51.82 $80,922 - $149,604
-2,887 Reduced 11.27%
22,731 $1.02 Million
Q4 2023

Feb 12, 2024

SELL
$20.06 - $28.66 $34,844 - $49,782
-1,737 Reduced 6.35%
25,618 $704,000
Q3 2023

Nov 14, 2023

BUY
$20.13 - $27.29 $19,344 - $26,225
961 Added 3.64%
27,355 $645,000
Q2 2023

Aug 14, 2023

SELL
$18.33 - $27.18 $25,955 - $38,486
-1,416 Reduced 5.09%
26,394 $694,000
Q1 2023

May 15, 2023

BUY
$14.25 - $20.5 $15,532 - $22,345
1,090 Added 4.08%
27,810 $511,000
Q4 2022

Feb 14, 2023

SELL
$12.8 - $23.66 $19,532 - $36,105
-1,526 Reduced 5.4%
26,720 $413,000
Q3 2022

Nov 14, 2022

SELL
$18.64 - $28.93 $26,897 - $41,745
-1,443 Reduced 4.86%
28,246 $566,000
Q2 2022

Aug 15, 2022

BUY
$13.98 - $29.25 $93,512 - $195,653
6,689 Added 29.08%
29,689 $672,000
Q1 2022

May 13, 2022

BUY
$23.58 - $30.91 $542,340 - $710,930
23,000 New
23,000 $608,000

Others Institutions Holding MRUS

About Merus N.V.


  • Ticker MRUS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,878,200
  • Market Cap $2.28B
  • Description
  • Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...
More about MRUS
Track This Portfolio

Track State Of Wisconsin Investment Board Portfolio

Follow State Of Wisconsin Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wisconsin Investment Board with notifications on news.